EUVIMEDEUVIMED entdecken
Crossref

Attenuation imaging and hepatorenal index composite score for the noninvasive assessment of hepatic steatosis in chronic liver disease: a prospective multicenter study

Tamami Abe, Hidekatsu Kuroda, Takashi Nishimura, Masahiro Yoshida, Shunya Kuroiwa, Yudai Fujiwara, Hirohisa Yano, Takayuki Matsumoto, Hiroko Iijima

Journal of Medical Ultrasonics · 23.06.2026

DOI: 10.1007/s10396-026-01655-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Ultrasonics, online erschienen am 23.06.2026. Verfasst von Tamami Abe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba, Sh…. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The increasing prevalence of steatotic liver disease (SLD) underscores the need for reliable, noninvasive tools to assess hepatic steatosis. Existing methods, such as the controlled attenuation parameter (CAP) under ultrasound, have limitations in accuracy. This study aimed to examine whether combining attenuation imaging (AI) and hepatorenal index (HRI) measurements improves discrimination of steatosis in participants with chronic liver disease (CLD). METHODS: This multicenter prospective cohort study enrolled 121 participants with CLD from two centers during 2022-2023. All participants underwent liver biopsy and ultrasound examinations, including AI and HRI measurements using a Philips EPIQ system, and CAP assessment. An AI-HRI composite score was developed using logistic regression and evaluated against individual variables through receive operating characteristic analysis, category-free net reclassification improvement (cf-NRI), and integrated discrimination improvement (IDI). Internal validation was performed using bootstrap sampling. RESULTS: The area under the curve values for discrimination for the AI-HRI composite score, AI, HRI, and CAP were 0.91, 0.87, 0.86, and 0.80, respectively. At a cutoff of -0.083, the sensitivity and specificity were 84.1% and 90.0%, respectively. The cf-NRI and IDI analyses demonstrated improved discrimination compared to other variables (p < 0.01). Bootstrap analysis confirmed the internal validity of the score (C-index: 0.90). CONCLUSIONS: The AI-HRI composite score provides superior discrimination of steatosis in participants with CLD, potentially offering a more accurate and reliable tool for clinical assessment. These findings could facilitate improved management and early intervention in SLD.

Schlagwörter

Stichwörter der Autor:innen

Attenuation imagingChronic liver diseaseHepatorenal indexSteatosis

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba, Shiwa, Iwate, 028-3695, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba, Shiwa, Iwate, 028-3695, Japan. hikuro@iwate-med.ac.jp.
  • Division of Hepatobiliary and Pancreatic Disease, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Japan.
  • Ultrasound Imaging Center, Hyogo Medical University Hospital, Nishinomiya, Japan.
  • Division of Clinical Laboratory, Saiseikai Futsukaichi Hospital, Chikushino, Japan.

Zitieren

APA

Abe, T., Kuroda, H., Nishimura, T., Yoshida, M., Kuroiwa, S., Fujiwara, Y., Yano, H., Matsumoto, T., & Iijima, H. (2026). Attenuation imaging and hepatorenal index composite score for the noninvasive assessment of hepatic steatosis in chronic liver disease: a prospective multicenter study. Journal of Medical Ultrasonics. https://doi.org/10.1007/s10396-026-01655-3

Vancouver

Abe T, Kuroda H, Nishimura T, Yoshida M, Kuroiwa S, Fujiwara Y, et al. Attenuation imaging and hepatorenal index composite score for the noninvasive assessment of hepatic steatosis in chronic liver disease: a prospective multicenter study. Journal of Medical Ultrasonics. 2026. doi:10.1007/s10396-026-01655-3

BibTeX
@article{Abe2026,
  author = {Abe, Tamami and Kuroda, Hidekatsu and Nishimura, Takashi and Yoshida, Masahiro and Kuroiwa, Shunya and Fujiwara, Yudai and Yano, Hirohisa and Matsumoto, Takayuki and Iijima, Hiroko},
  title = {Attenuation imaging and hepatorenal index composite score for the noninvasive assessment of hepatic steatosis in chronic liver disease: a prospective multicenter study},
  journal = {Journal of Medical Ultrasonics},
  year = {2026},
  doi = {10.1007/s10396-026-01655-3}
}
Kostenlos starten →